Fund Holdings — Sofinnova Investments, Inc.

Total Portfolio Value
$1.33B
Total Bought
$474.96M
Total Sold
$370.88M
Net Transaction
+$104.09M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Stryker Corporation(SYK)116,005298,567+182,56241,768111,1428.38%+69,374
Medtronic PLC(MDT)0562,992+562,992050,5903.82%+50,590
Eli Lilly & Co(LLY)14,36452,800+38,43611,08943,6083.29%+32,519
PTC Therapeutics Inc(PTCT)0579,339+579,339029,5232.23%+29,523
BridgeBio Pharma Inc(BBIO)0734,227+734,227025,3821.91%+25,382
Blueprint Medicines Corp0261,039+261,039023,1051.74%+23,105
Bristol-Myers Squibb Co(BMY)0371,497+371,497022,6581.71%+22,658
Alnylam Pharmaceuticals Inc(ALNY)110,157176,181+66,02425,92147,5723.59%+21,651
Akero Therapeutics Inc0510,020+510,020020,6461.56%+20,646
AnaptysBio Inc132,9271,160,033+1,027,1061,76021,5651.63%+19,805
Syndax Pharmaceuticals Inc(SNDX)658,6272,275,223+1,616,5968,70727,9512.11%+19,244
Supernus Pharmaceuticals Inc(SUPN)0520,678+520,678017,0521.29%+17,052
IDEAYA Biosciences Inc(IDYA)1,069,0902,622,192+1,553,10227,47642,9523.24%+15,476
Roivant Sciences Ltd(ROIV)01,279,510+1,279,510012,9100.97%+12,910
Penumbra Inc(PEN)042,936+42,936011,4820.87%+11,482
Avidity Biosciences Inc13,789379,931+366,14240111,2160.85%+10,815
Danaher Corporation(DHR)10,00058,606+48,6062,29612,0140.91%+9,719
Arcus Biosciences Inc(RCUS)01,037,776+1,037,77608,1470.61%+8,147
Cogent Biosciences Inc(COGT)823,1602,182,121+1,358,9616,42113,0710.99%+6,650
Praxis Precision Medicines I(PRAX)0157,640+157,64005,9700.45%+5,970
Uniqure NV(QURE)0545,771+545,77105,7850.44%+5,785
Insmed Inc(INSM)256,281304,254+47,97317,69423,2121.75%+5,518
Kura Oncology Inc(KURA)0791,667+791,66705,2250.39%+5,225
Immatics N.V(IMTX)343,2061,554,304+1,211,0982,4407,0100.53%+4,570
Dexcom Inc(DXCM)290,210395,975+105,76522,57027,0412.04%+4,472
Scholar Rock Hldg Corp(SRRK)0116,117+116,11703,7330.28%+3,733
Inhibrx Biosciences Inc(INBX)527,190697,916+170,7268,1199,7640.74%+1,645
Rhythm Pharmaceuticals(RYTM)397,428446,839+49,41122,24823,6691.78%+1,421
Jazz Pharmaceuticals PLC(JAZZ)504,193510,050+5,85762,09163,3234.78%+1,231
Metsera Inc036,800+36,80001,0020.08%+1,002
Soleno Therapeutics Inc757,248484,471-272,77734,03834,6152.61%+577
Structure Therapeutics Inc20,89234,952+14,0605676050.05%+38
Enliven Therapeutics Inc34,02533,547-4787666600.05%-105
Ikena Oncology Inc382,616382,61606274900.04%-138
Vir Biotechnology Inc(VIR)114,13183,010-31,1218385380.04%-300
Bolt Biotherapeutics Inc2,754,4372,754,43701,4741,1020.08%-372
Pulmonx Corp(LUNG)61,3260-61,3264160—-416
Aerovate Therapeutics Inc3,758,6863,758,68609,9619,4340.71%-526
Travere Therapeutics Inc(TVTX)32,6160-32,6165680—-568
ICU Med Inc(ICUI)5,0000-5,0007760—-776
Nextcure Inc2,671,8562,671,85602,0601,2830.10%-777
Disc Medicine Inc(IRON)22,7527,485-15,2671,4423720.03%-1,071
Becton Dickinson & Co(BDX)4,9510-4,9511,1230—-1,123
Pharvaris N V
COM
560,723593,403+32,68010,7499,3160.70%-1,433
Keros Therapeutics Inc(KROS)95,3750-95,3751,5100—-1,510
Savara Inc(SVRA)5,471,2995,481,666+10,36716,79715,1841.15%-1,613
Erasca Inc(ERAS)1,795,8801,877,085+81,2054,5082,5720.19%-1,936
Immunome Inc(IMNM)746,824788,666+41,8427,9315,3080.40%-2,624
Exact Sciences Corp(EXK)52,0420-52,0422,9240—-2,924
Edwards Lifesciences Corp40,0000-40,0002,9610—-2,961
Establishment Labs Hldgs Inc(ESTA)95,30528,675-66,6304,3911,1700.09%-3,221
Edgewise Therapeutics Inc(EWTX)402,773342,218-60,55510,7547,5290.57%-3,225
Avantor Inc(AVTR)200,0000-200,0004,2140—-4,214
Achieve Life Sciences Inc1,306,4820-1,306,4824,5990—-4,599
BioAge Labs Inc(BIOA)2,304,9012,304,901013,3458,6660.65%-4,679
Y-mAbs Therapeutics Inc2,194,2782,194,278017,1819,7210.73%-7,461
Inozyme Pharma Inc4,280,3084,280,308011,8563,8950.29%-7,961
Inari Med Inc180,4560-180,4569,2120—-9,212
Janux Therapeutics Inc(JANX)253,2620-253,26213,5600—-13,560
Arrivent BioPharma Inc(AVBP)1,696,7521,696,752045,20131,3732.37%-13,829
Intuitive Surgical Inc37,89611,984-25,91219,7805,9350.45%-13,845
Replimune Group Inc(REPL)3,149,5222,479,939-669,58338,14124,1791.82%-13,961
Incyte Corp(INCY)524,267357,800-166,46736,21121,6651.63%-14,546
Rapport Therapeutics Inc(RAPP)1,995,5941,995,594035,40220,0161.51%-15,386
Dyne Therapeutics Inc(DYN)1,071,498716,896-354,60225,2447,4990.57%-17,746
Globus Med Inc(GMED)244,7000-244,70020,2390—-20,239
Axsome Therapeutics Inc(AXSM)491,726175,317-316,40941,60520,4471.54%-21,158
Gilead Sciences Inc(GILD)774,227418,900-355,32771,51546,9383.54%-24,578
Alkermes Plc(ALKS)894,2660-894,26625,7190—-25,719
Natera Inc(NTRA)1,550,2801,550,2800245,409219,22516.53%-26,184
Boston Scientific Corp(BSX)346,5710-346,57130,9560—-30,956
Sarepta Therapeutics Inc(SRPT)428,771327,618-101,15352,13420,9091.58%-31,226
AstraZeneca PLC(AZN)651,3440-651,34442,6760—-42,676
Vera Therapeutics Inc(VERA)2,793,9872,793,9870118,15867,1125.06%-51,046
AbbVie Inc(ABBV)359,3930-359,39363,8640—-63,864
Page 1 of 1
Sofinnova Investments, Inc. — 13F Holdings — Q1 2025 | TickerTrail